← Back to front page
United States · Exchanges & live quotes · Nasdaq

Amgen vs. Johnson & Johnson: Which Healthcare Giant Has the Better Stock to Buy?

Published by Nasdaq · United States 1 h ago

Key PointsAmgen focuses on high-growth areas including oncology, inflammation, and rare diseases to drive its clinical pipeline.

Read the full article on Nasdaq Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.nasdaq.com)

Also worth reading

OilPrice.com

Can Undersea Volcanoes Power Cities? A Seattle Startup Just Took the First Step

 CoinMarketCap

Worldcoin Drops 13% as Institution Moves 19.7M WLD

 Investopedia

Are You Earning More or Less Than Others Your Age? New Fed Data Reveals the Answer

 Cboe Global Markets

Tech Sell-Off Leads to Uptick in Defensive Stocks

 Google Finance

Introducing new self-learning context enrichment in Knowledge Catalog

 CNN Markets

Subtropical Storm Josephine heads away from East Coast